全身MRI在转移性小叶乳腺癌中的附加价值综述
综述探讨全身MRI(WBMRI)在评估转移性浸润性小叶癌(ILC)中的附加价值,并与CT和FDG-PET/CT比较。ILC转移模式特殊,常累及腹膜、腹膜后及胃肠道/泌尿生殖道,骨和肝最常见;骨-only/骨为主型使CT评估受限。WBMRI可功能评估病灶,较CT检出更多部位、更早显示进展,部分ILC非FDG高摄取致PET/CT低估范围。
要点
- ILC转移模式特殊:腹膜、腹膜后、胃肠道及泌尿生殖道受累,骨和肝最常见。
- 骨-only/骨为主型转移性ILC用CT评估疾病状态受限,WBMRI可提供功能信息。
- WBMRI较CT可检出更多病灶部位并更早显示进展,部分ILC非FDG高摄取致PET/CT低估范围。
核心结论
- WBMRI在转移性ILC评估中具有附加价值,尤其骨-only/骨为主型;较CT可检出更多病灶部位并更早显示进展,部分ILC非FDG高摄取致FDG-PET/CT低估范围。
研究设计与样本
- 综述,检索范围与纳入文献原文未报告;比较WBMRI与CT、FDG-PET/CT在转移性ILC评估中的价值。
关键影像表现/征象
- ILC转移模式不同于IDC:可转移至腹膜、腹膜后及胃肠道/泌尿生殖道,骨和肝为最常见部位。
- 骨-only/骨为主型转移性ILC在CT上疾病状态评估受限。
- WBMRI通过反映良恶性组织细胞密度差异的功能信息评估骨和软组织病变。
- 部分ILC非FDG高摄取,FDG-PET/CT可低估疾病范围。
诊断标准与关键数值
- WBMRI与FDG-PET/CT在转移性乳腺癌评估中性能相当。
- 近期多项研究显示WBMRI可检出转移性乳腺癌额外病灶部位,导致全身抗肿瘤治疗改变。
临床应用与阅片要点
- 对骨-only/骨为主型转移性ILC,CT评估疾病状态受限,WBMRI可提供功能评估。
- WBMRI较CT可检出更多病灶部位并更早显示进展,有机会更早改变无效的全身治疗。
- 部分ILC非FDG高摄取,FDG-PET/CT可能低估疾病范围,WBMRI可特别有价值。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Invasive lobular breast carcinomas (ILC) account for approximately 15% of breast cancer diagnoses. They can be difficult to diagnose both clinically and radiologically, due to their infiltrative growth pattern. The pattern of metastasis of ILC is unusual, with spread to the serosal surfaces (pleura and peritoneum), retroperitoneum and gastrointestinal (GI)/genitourinary (GU) tracts and a higher rate of leptomeningeal spread than IDC. Routine staging and response assessment with computed tomography (CT) can be undertaken quickly and measurements can be reproduced easily, but this is challenging with metastatic ILC as bone-only/bone-predominant patterns are frequently seen and assessment of the disease status is limited in these scenarios. Functional imaging such as whole-body MRI (WBMRI) allows the assessment of bone and soft tissue disease by providing functional information related to differences in cellular density between malignant and benign tissues. A number of recent studies have shown that WBMRI can detect additional sites of disease in metastatic breast cancer (MBC), resulting in a change in systemic anti-cancer therapy. Although WBMRI and fluorodeoxyglucose-positron-emission tomography-computed tomography (FDG-PET/CT) have a comparable performance in the assessment of MBC, WBMRI can be particularly valuable as a proportion of ILC are non-FDG-avid, resulting in the underestimation of the disease extent. In this review, we explore the added value of WBMRI in the evaluation of metastatic ILC and compare it with other imaging modalities such as CT and FDG-PET/CT. We also discuss the spectrum of WBMRI findings of the different metastatic sites of ILC with CT and FDG-PET/CT correlation. KEY POINTS: • ILC has an unusual pattern of spread compared to IDC, with metastases to the peritoneum, retroperitoneum and GI and GU tracts, but the bones and liver are the commonest sites. • WBMRI allows functional assessment of metastatic disease, particularly in bone-only and bone-predominant metastatic cancers such as ILC where evaluation with CT can be challenging and limited. • WBMRI can detect more sites of disease compared with CT, can reveal disease progression earlier and provides the opportunity to change ineffective systemic treatment sooner.
引用
- Bhaludin, Tunariu, Koh, et al. A review on the added value of whole-body MRI in metastatic lobular breast cancer. Eur Radiol. 2022. PMID: 35384456. doi:10.1007/s00330-022-08714-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。